NCT00349219 TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00345059 The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer Status TERMINATED Phase PHASE3
NCT00330746 CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00319514 Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC Status COMPLETED Phase PHASE2
NCT00161278 Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling Status TERMINATED Phase PHASE2
NCT00064636 Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors Status TERMINATED Phase PHASE1